Resources Center

Liaison Technologies offers tailored cloud enterprise application integration and data management solutions.

Laerdal is an international market leader in the field of Basic and Advanced Life Support training and treatment equipment. Laerdal is dedicated to helping save lives with products for CPR training, Airway Management, Advanced Life Support Training, Spinal Motion restriction, Trauma Training, Monitoring, Defibrillation, Patient Simulation made for using traditional basic, intermediate and advanced training techniques combined with micro simulation and virtual reality. The products are used, among others, by hospitals, ambulance services, first aid organizations, the military and by industrial worldwide. The company’s head office is situated in the Norwegian city of Stavanger. Worldwide Laerdal is represented in North America, Europe, Asia & the Pacific.

ITA Group creates and manages events, incentives and recognition programs that align and motivate people.

Intuit Inc. is a business and financial software company that develops and sells financial, accounting and tax preparation software and related services for small businesses, accountants and individuals. Intuit makes TurboTax, a consumer tax preparation application, the small business accounting program QuickBooks, professional tax solutions ProSeries and Lacerte, and multiple payroll products.

Incentive Networks provides a private-label, merchant-funded loyalty marketing platform for roughly 400 partners utilizing 3,500 retailers who use it to create a customized online shopping environment, offer discounts to valued customers, and monitor transactions on partners’ sites. Incentive Networks is a contributing division of a corporation that generated $193 million in 2007, and has had 20 successful operating quarters.

Heart Test Laboratories provides accurate, affordable screening tools for the early detection of heart disease through the continuous development of innovative electrocardiography. The company’s primary solution, MyoVista, is a low-cost, accurate screening test that helps assess heart disease—the leading cause of death and the largest spend area in healthcare. After $15M and eight years of time investment, research and development were completed in 2016. MyoVista then moved into production with units shipping in early 2017.